Link Technologies and the PNA Inventor Group entered into a nonexclusive license agreement to allow Link Technologies to manufacture and sell monomers for peptide nucleic acid (PNA) synthesis worldwide under the PNA Inventor Group’s patents.
Recent estimates predict that PNA synthesis will account for 10% of the global DNA synthesis market by 2010, a market presently worth $800 million and growing at over 10% per year, according to Link.
Initially, Link says that it will be offering the preferred Fmoc/Bhoc protected PNA monomers. These monomers are compatible with commercial automated oligonucleotide, peptide, or combinatorial synthesizers. The company anticipates that these products will be available next month.